EP3419629A1 Anti-Infective Compositions, Applied Biological Laboratories, Apr 15
Summary
The European Patent Office published application EP3419629A1 on April 15, 2026, titled 'Compositions for Protecting Against Airborne Pathogens and Irritants.' The patent names Applied Biological Laboratories, Inc. as applicant and Nazlie Latefi as inventor, with IPC classifications including A61P 31/00 (anti-infectives) and A61P 31/16 (antivirals), designating 37 European Patent Convention member states.
Patent holders gain enforceable exclusivity over the claimed compositions in designated states; third parties manufacturing similar anti-infective formulations without license may face infringement claims.
About this source
GovPing monitors EPO Patent Bulletin - Therapeutics (A61P) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 17 changes logged to date.
What changed
The European Patent Office published EP3419629A1 on April 15, 2026, titled 'Compositions for Protecting Against Airborne Pathogens and Irritants.' The patent names Applied Biological Laboratories, Inc. as applicant and Nazlie Latefi as inventor, with IPC classifications including A61P 31/00 (anti-infectives) and A61P 31/16 (antivirals), designating 37 European Patent Convention member states.
Patent holders gain enforceable exclusivity over the claimed compositions in designated states; third parties manufacturing similar anti-infective formulations without license may face infringement claims.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITIONS FOR PROTECTING AGAINST AIRBORNE PATHOGENS AND IRRITANTS
Publication EP3419629A1 Kind: A1 Apr 15, 2026
Applicants
Applied Biological Laboratories, Inc.
Inventors
LATEFI, Nazlie
IPC Classifications
A61K 31/702 20060101AFI20260309BHEP A61K 38/40 20060101ALI20260309BHEP A61K 38/47 20060101ALI20260309BHEP A61K 45/06 20060101ALI20260309BHEP A61P 31/00 20060101ALI20260309BHEP A61K 9/00 20060101ALI20260309BHEP A61K 38/17 20060101ALI20260309BHEP A61K 31/731 20060101ALI20260309BHEP A61K 33/30 20060101ALI20260309BHEP A61K 33/34 20060101ALI20260309BHEP A61K 33/38 20060101ALI20260309BHEP A61K 47/10 20170101ALI20260309BHEP A61P 31/16 20060101ALI20260309BHEP A61K 31/7012 20060101ALI20260309BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.